LIF Antikörper (Internal Region)
Kurzübersicht für LIF Antikörper (Internal Region) (ABIN7013860)
Target
Alle LIF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
-
-
Bindungsspezifität
- Internal Region
-
Verwendungszweck
- LIF
-
Sequenz
- RLCSKYHVGH VDVT
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
-
-
-
-
Applikationshinweise
-
Immunohistochemistry: Paraffin embedded Human Testis. Recommended concentration: 6 μg/mL.
Peptide ELISA: antibody detection limit dilution 1:128000.
-
Kommentare
-
Flow Cytometry: Flow cytometric analysis of HepG2 cells. Recommended concentration: 10ug/ml.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Minimize freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
-
- LIF (Leukemia Inhibitory Factor (LIF))
-
Andere Bezeichnung
- LIF
-
Hintergrund
- LIF, leukemia inhibitory factor (cholinergic differentiation factor), CDF, DIA, HILDA, D factor, MLPLI, OTTHUMP00000198698, cholinergic differentiation factor, differentiation inhibitory activity, differentiation stimulating factor, differentiation-induci
-
Gen-ID
- 3976
-
Pathways
- JAK-STAT Signalweg, Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, Stem Cell Maintenance, Growth Factor Binding
Target
-